ArticleCancer communications (London, England)2022

ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients.

Dingxie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.